| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 1,170 | 1,210 | 01.10. |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mi | CMS (00867): CHANGE OF COMPANY NAME OF SINGAPORE SHARE TRANSFER AGENT | - | HKEx | ||
| 14.09. | CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR SYSTEMIC LUPUS ERYTHEMATOSUS OF INNOVATIVE DRUG HIGHLY SELECTIVE ... | 1 | HKEx | ||
| 09.09. | China Medical System Holdings Limited: CMS: Initial Prescriptions for Silevimig Injection, the World's First Bispecific Antibody Against Rabies, Issued in China | 7.302 | JCN Newswire | SHENZHEN, Sept 9, 2026 - (ACN Newswire) - On 9 September, China Medical System Holdings Limited (867.HK/8A8.SG) ("CMS" or the "Group") is pleased to announce that the initial prescriptions for the Class... ► Artikel lesen | |
| 09.09. | China Medical System Holdings Ltd.: CMS: Initial Prescriptions for Silevimig Injection, the World's First Bispecific Antibody Against Rabies, Issued in China | 2 | GlobeNewswire (USA) | ||
| 04.09. | China Medical System Holdings Limited: CMS (867.HK/8A8.SG): Innovative Drug Lumirix(R) Approved in China for Additional Indication of Atopic Dermatitis (AD) | 621 | JCN Newswire | SHENZHEN, CHINA, Sept 4, 2026 - (ACN Newswire) - China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that its subsidiary, Dermavon Holdings Limited ("Dermavon", an innovative... ► Artikel lesen | |
| CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln | |||||
| 03.09. | China Medical System Holdings Ltd.: CMS(867.HK/8A8.SG): Innovative Drug Lumirix Approved in China for Additional Indication of Atopic Dermatitis (AD) | 278 | GlobeNewswire (Europe) | SHENZHEN, CHINA, Sept. 03, 2026 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that its subsidiary, Dermavon Holdings Limited ("Dermavon",... ► Artikel lesen | |
| 03.09. | CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR ADDITIONAL INDICATION ATOPIC DERMATITIS (AD) FOR RUXOLITINIB PHOSPHATE ... | 1 | HKEx | ||
| 01.09. | CMS (00867): LETTER TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS ... | 3 | HKEx | ||
| 01.09. | CMS (00867): LETTER TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND ... | 2 | HKEx | ||
| 01.09. | CMS (00867): INTERIM REPORT 2026 | - | HKEx | ||
| 28.08. | Dividendenbekanntmachungen (28.08.2026) | 16.758 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 361 DEGREES INTERNATIONAL LTD KYG884931042 0,222 HKD 0,0243 EUR ABC-MART INC JP3152740001 40 JPY 0,2152 EUR ADMIE IPTO HOLDING... ► Artikel lesen | |
| 18.08. | CMS (00867): (REVISED) INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2026 | 1 | HKEx | ||
| 17.08. | China Medical System Holdings Limited Bottom Line Rises In H1 | 2 | RTTNews | ||
| 17.08. | CMS (00867): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2026 | 1 | HKEx | ||
| 17.08. | CMS (00867): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2026 | - | HKEx | ||
| 05.08. | CMS (00867): NOTICE OF BOARD MEETING | - | HKEx | ||
| 15.07. | CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR AGE-RELATED MACULAR DEGENERATION INDICATION OF SELF-DEVELOPED ... | - | HKEx | ||
| 29.06. | CMS (00867): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | - | HKEx | ||
| 29.06. | CMS (00867): APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR | 1 | HKEx | ||
| 22.06. | China Medical System Holdings Limited: CMS: Class 1 Innovative Drug Silevimig Injection Approved in China, Becoming the World's First Bispecific Antibody for Passive Immunization Against Rabies | 472 | JCN Newswire | SHENZHEN, June 22, 2026 - (ACN Newswire) - China Medical System Holdings Limited (867.HK/8A8.SG) ("CMS", or the "Group") is pleased to announce that, the New Drug Application for Silevimig Injection... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 43,800 | -2,12 % | Fresenius baut Kapazität in Europa für 54 Mio Euro aus | DJ Fresenius baut Kapazität in Europa für 54 Mio Euro aus
DOW JONES--Fresenius hat seine Kapazitäten für die Herstellung von Infusionslösungen in Polen und Italien erweitert. Wie der DAX-Konzern... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,680 | +0,28 % | Fresenius Medical Care: China sorgt für eine Millionenbelastung | Fresenius Medical Care stellt sein Geschäft in China neu auf und nimmt dafür eine erhebliche Belastung in Kauf. Der Dialysekonzern rechnet im dritten Quartal 2026 mit Sonderaufwendungen von rund 110... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 37,610 | -0,95 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 31,200 | -0,26 % | 12 Prozent bessere Leistung, 14 Prozent weniger Belastung: Warum ZEISS das Brillenglas neu denkt - und wo Rise Nano Optics ins Spiel kommt | ||
| ECKERT & ZIEGLER | 12,330 | -3,22 % | Eckert&Ziegler mit WARNUNG: Diese kritische Marke lässt Anleger zittern - Das dürfen Sie nicht verpassen! | ||
| INTUITIVE SURGICAL | 357,80 | +0,25 % | Is Wall Street Dead Wrong About Intuitive Surgical? Here's My Honest Answer. | ||
| UNITEDHEALTH | 325,00 | +0,06 % | UnitedHealthcare Unveils FY27 Medicare Advantage Plans | MINNETONKA (dpa-AFX) - Health care and well-being major UnitedHealth Group Inc. (UNH) Thursday introduced its 2027 Medicare Advantage plans, focused on affordability, simplicity and a more connected... ► Artikel lesen | |
| DRAEGERWERK | 118,80 | -1,66 % | Drägerwerk-Aktie // Dicker Freudensprung | Bei Drägerwerk läuft das Geschäft weiterhin sehr gut. Dies belegen überzeugende Zahlen für das erste Halbjahr. So erhöhte sich der Umsatz um 6,2 Prozent auf rund 1,6 Milliarden Euro. Bereinigt wäre... ► Artikel lesen | |
| MEDTRONIC | 76,90 | -0,05 % | Dividendenbekanntmachungen (25.09.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ADF GROUP INC CA00089N1033 0,02 CAD 0,0124 EUR ALERUS FINANCIAL CORPORATION US01446U1034 0,22 USD 0,1933 EUR ASMODEE GROUP AB SE0023615638 - 0... ► Artikel lesen | |
| GERRESHEIMER | 27,720 | -4,22 % | EQS-AFR: Gerresheimer AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | EQS Vorabbekanntmachung Finanzberichte: Gerresheimer AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Gerresheimer AG: Vorabbekanntmachung über... ► Artikel lesen | |
| THERMO FISHER | 580,20 | -0,07 % | Thermo Fisher Scientific and Evosep Enter Reseller Agreement for Evosep Eno | Thermo Fisher Scientific to offer the Evosep Eno separation platform to customers, expanding access to standardized, high-throughput proteomics workflowsSINGAPORE, Sept. 28, 2026 (GLOBE NEWSWIRE) --... ► Artikel lesen | |
| TELADOC HEALTH | 5,130 | +1,79 % | Teladoc Health, Inc.: Teladoc Health Announces Chief Legal Officer Transition | NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, today announced a leadership transition in its legal function. After 11 years with... ► Artikel lesen | |
| STRATEC | 21,650 | -1,59 % | EQS-PVR: STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: STRATEC SE
STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,740 | 0,00 % | Are Options Traders Betting on a Big Move in Alignment Healthcare Stock? | ||
| NEXALIN TECHNOLOGY | 7,550 | 0,00 % | Nexalin Technology, Inc.: Nexalin Technology Signs Definitive Exclusive Distribution and Local Manufacturing Agreement for Brazil and South America, Marking a Major Step in its Transition Toward Commercial Revenue Generation | Agreement establishes an initial 100-device commercialization program for the ANVISA-approved Nexalin Sync across seven countries and more than 300 million people, with a structured pricing framework... ► Artikel lesen |